Literature DB >> 9149241

Leishmania spp.: nitric oxide-mediated metabolic inhibition of promastigote and axenically grown amastigote forms.

J L Lemesre1, D Sereno, S Daulouède, B Veyret, N Brajon, P Vincendeau.   

Abstract

The antimicrobial effect of activated macrophages on parasites involves nitric oxide (NO). NO induces intracellular parasite killing in murine leishmaniasis. Nevertheless, the mechanisms of action of NO as a final effector molecule on intracellular forms of Leishmania are unknown. The recent development of axenically grown amastigote forms of different Leishmania species allowed direct investigation of NO activity on active and dividing populations of the mammalian stage of various Leishmania species, which normally are only found intracellularly. Authentic NO gas, which reproduced the antimicrobial effect elaborated by activated macrophages, was flushed on promastigote and axenically cultured amastigote forms of L. mexicana, L. amazonensis, and L. chagasi suspended in degassed phosphate-buffered saline (PBS). After NO treatment, the viability of parasites gradually decreased as a function of time postflushing when compared to controls. Interestingly NO killing was more effective on promastigote forms than on amastigote forms. After 12-hr postflushing incubation in PBS, cultures of NO-treated parasites, contrary to controls (N2-treated), failed to proliferate whatever the species and the developmental stage considered. Addition of both FeSO4 and L-cysteine to PBS immediately after NO treatment reversed the capacity of authentic NO gas to inhibit the multiplication of both parasite stages of Leishmania. Supplementation of PBS with alpha-ketoglutarate and cis-aconitate (citric acid cycle substrates) also reversed the leishmanicidal activity of NO, whereas addition of citrate was less effective. The course of the developmental life cycle in vitro was also inhibited by NO gas treatment. Enzymatic analysis showed that aconitase activity was dramatically reduced by NO gas, whereas glucose phosphate isomerase, aspartate transferase, and phosphoglucomutase activities were unchanged. In accordance, promastigote and amastigote forms of Leishmania were shown to be killed by antimycin A, an inhibitor of mitrochondrial respiration. All these data demonstrated that NO action led to lethal metabolic inhibition in both developmental parasite stages by, at least in part, triggering iron loss from enzyme(s) with iron-sulfur prosthetic groups, in particular aconitase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149241     DOI: 10.1006/expr.1997.4151

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  14 in total

1.  Selective effect of 2',6'-dihydroxy-4'-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis.

Authors:  E C Torres-Santos; D L Moreira; M A Kaplan; M N Meirelles; B Rossi-Bergmann
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced.

Authors:  D Sereno; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

3.  Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes.

Authors:  D Sereno; P Holzmuller; I Mangot; G Cuny; A Ouaissi; J L Lemesre
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

5.  CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice.

Authors:  Rene E Vasquez; Lynn Soong
Journal:  Infect Immun       Date:  2006-09-18       Impact factor: 3.441

6.  Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production.

Authors:  Anselmo S Souza; Angela Giudice; Júlia Mb Pereira; Luís H Guimarães; Amelia R de Jesus; Tatiana R de Moura; Mary E Wilson; Edgar M Carvalho; Roque P Almeida
Journal:  BMC Infect Dis       Date:  2010-07-15       Impact factor: 3.090

Review 7.  L-arginine metabolism and its impact on host immunity against Leishmania infection.

Authors:  Nanchaya Wanasen; Lynn Soong
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

8.  A novel organotellurium compound (RT-01) as a new antileishmanial agent.

Authors:  Camila Bárbara Cantalupo Lima; Wagner Welber Arrais-Silva; Rodrigo Luiz Oliveira Rodrigues Cunha; Selma Giorgio
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

9.  Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes.

Authors:  Philippe Holzmuller; Denis Sereno; Mireille Cavaleyra; Isabelle Mangot; Sylvie Daulouede; Philippe Vincendeau; Jean-Loup Lemesre
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

10.  Antileishmanial activity of warifteine: a bisbenzylisoquinoline alkaloid isolated from Cissampelos sympodialis Eichl. (Menispermaceae).

Authors:  Eliete Cavalcanti da Silva; Cynthia Dias Rayol; Paloma Lys Medeiros; Regina Célia Bressan Queiroz Figueiredo; Márcia Regina Piuvezan; José Maria Brabosa-Filho; Alexsandro Fernandes Marinho; Teresinha Gonçalves Silva; Gardenia Carmen Gadelha Militão; Ana Paula Pimentel Cassilhas; Paulo Paes de Andrade
Journal:  ScientificWorldJournal       Date:  2012-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.